Goldman Sachs cuts Nanobiotix stake to 3.78% of capital, 3.52% voting rights

PUBT · 2d ago
Goldman Sachs cuts Nanobiotix stake to 3.78% of capital, 3.52% voting rights
  • Goldman Sachs cut its stake in Nanobiotix below 5% on Aug. 24, holding 1,921,176 shares.
  • Position equals 3.78% of share capital, 3.52% of voting rights.
  • Move followed an off-market sale of shares.
  • Holding includes 1,478,840 shares via 17 cash-settled swap contracts, exercisable between Sept. 4, 2026 and Aug. 20, 2036.
  • Goldman also held 18,485 shares tied to a stock loan with a right to recall.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief on August 28, 2026, and is solely responsible for the information contained therein.